REGN

Regeneron Pharmaceuticals Inc

Price:

971.19

USD

Volume:

420,118.00

United States | Biotechnology

-7.28 %

Upside

As of 2024-03-05, the Fair Value of Regeneron Pharmaceuticals Inc (REGN) is 900.51 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 971.19 USD, the upside of Regeneron Pharmaceuticals Inc is -7.28%.

971.19 USD

Stock Price

900.51 USD

Fair Price

Peter Lynch's formula is:

Regeneron Fair Value

= Earnings Growth Rate x TTM EPS
Regeneron Fair Value

= 25.00 x 36.02
Regeneron Fair Value

= 900.51
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | 2,116.00 | 3,513.00 | 8,075.00 | 4,338.00 | 3,953.60 | 4,399.12 |

YoY growth | -13.42% | 66.02% | 129.86% | -46.28% | -8.86% | 25.46% |

Market Cap (mil) | 106,597.81 |

P/E | 26.96x |

Forward P/E | 26.51x |

EPS | 36.02 |

Avg earnings growth rate | 25.46% |

TTM earnings | 3,953.60 |